[Immunoscintigraphy of the hematopoietic bone marrow in osteomyelofibrosis].
In planning the treatment of splenomegaly in primary or secondary osteomyelofibrosis it is necessary to know whether there is any significant hematopoiesis outside the spleen. In contrast to the measurement of iron kinetics with 59Fe, which is not suitable for imaging, immunoscintigraphy with the monoclonal antibody Bw 250/183 allows specific imaging of the hematopoietic bone marrow. The diagnostic use of this method in addition to iron kinetics is illustrated and discussed in a patient with primary osteomyelofibrosis.
Bartenstein
P
P
Klinik und Poliklinik für Nuklearmedizin, Westfälische Wilhelms-Universität, Münster, BR Deutschland.
Kirchner
B
B
Scheidhauer
K
K
Schober
O
O
D000911:Antibodies, Monoclonal; D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000276:immunology; D005260:Female; D006410:Hematopoiesis / Q000502:physiology*; D006801:Humans; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000000981:diagnostic imaging* / Q000503:physiopathology; D011877:Radionuclide Imaging; D013667:Technetium
D000911:Antibodies, Monoclonal; D013667:Technetium
Immunszintigraphie des hämatopoetischen Knochenmarks bei Osteomyelofibrose.